Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  Hangzhou Tigermed Consulting Co.,Ltd    300347   CNE100001KV8

HANGZHOU TIGERMED CONSULTING CO.,LTD

(300347)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Hangzhou Tigermed Consulting Co.,Ltd : half-yearly earnings release

08/21/2020 | 09:15am EST

The company will report its earnings for S1 2020 on 08/26/2020. Generally, the company reports earnings in line with the consensus. In recent months, the 9 analysts from Standard & Poor's consensus have not revised their EPS estimates.


© MarketScreener.com 2020
All news about HANGZHOU TIGERMED CONSULTING CO.,LTD
2020HANGZHOU TIGERMED CONSULTING : Full exercise of the over-allotment option, stabi..
PU
2020HANGZHOU TIGERMED CONSULTING : (1) proposed partial repurchase and cancellation ..
PU
2020HANGZHOU TIGERMED CONSULTING CO.,LTD : half-yearly earnings release
2020HANGZHOU TIGERMED CONSULTING : 2019 Sustainability Report
PU
2020HANGZHOU TIGERMED CONSULTING : Terms of reference for the strategy development c..
PU
2020HANGZHOU TIGERMED CONSULTING : Terms of reference of the nomination committee of..
PU
2020HANGZHOU TIGERMED CONSULTING : Terms of reference of the remuneration and evalua..
PU
2020HANGZHOU TIGERMED CONSULTING : Terms of reference of the audit committee of the ..
PU
2020HANGZHOU TIGERMED CONSULTING : Articles of association
PU
2020HANGZHOU TIGERMED CONSULTING : China's Tigermed to raise up to $1.38 billion in ..
RE
More news
Financials
Sales 2020 3 316 M 512 M 512 M
Net income 2020 1 526 M 236 M 236 M
Net cash 2020 13 459 M 2 078 M 2 078 M
P/E ratio 2020 88,0x
Yield 2020 0,27%
Capitalization 138 B 21 234 M 21 282 M
EV / Sales 2020 37,5x
EV / Sales 2021 28,7x
Nbr of Employees -
Free-Float 100,0%
Chart HANGZHOU TIGERMED CONSULTING CO.,LTD
Duration : Period :
Hangzhou Tigermed Consulting Co.,Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HANGZHOU TIGERMED CONSULTING CO.,LTD
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Average target price 155,53 CNY
Last Close Price 159,06 CNY
Spread / Highest target 25,7%
Spread / Average Target -2,22%
Spread / Lowest Target -26,9%
EPS Revisions
Managers and Directors
NameTitle
Xiao Ping Ye Chairman & General Manager
Xiao Li Shi Chairman-Supervisory Board
Jun Gao Chief Financial Officer & Senior Vice President
Xiao Chun Cao Secretary, Director & Deputy General Manager
Zhi Min Chen Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
HANGZHOU TIGERMED CONSULTING CO.,LTD-1.58%21 572
MODERNA, INC.24.10%51 304
LONZA GROUP AG2.46%48 618
CELLTRION, INC.-12.95%38 786
IQVIA HOLDINGS INC.4.81%36 004
SEAGEN INC.6.06%33 601